Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Not all profitable companies are created equal, and that’s why we built StockStory - to help you find the ones that truly shine bright. That said, here are three profitable companies to avoid and some better opportunities instead.

Genesco (GCO)

Trailing 12-Month GAAP Operating Margin: 1.1%

Spanning a broad range of styles, brands, and prices, Genesco (NYSE: GCO) sells footwear, apparel, and accessories through multiple brands and banners.

Why Should You Sell GCO?

1. Weak same-store sales trends over the past two years suggest there may be few opportunities in its core markets to open new locations
2. Diminishing returns on capital from an already low starting point show that neither management’s prior nor current bets are going as planned
3. High net-debt-to-EBITDA ratio of 5× could force the company to raise capital at unfavorable terms if market conditions deteriorate

At $31.57 per share, Genesco trades at 14.7x forward P/E. Read our free research report to see why you should think twice about including GCO in your portfolio.

Sotera Health Company (SHC)

Trailing 12-Month GAAP Operating Margin: 31.1%

With a critical role in ensuring the safety of millions of patients worldwide, Sotera Health (NASDAQGS:SHC) provides sterilization services, lab testing, and advisory services to ensure medical devices, pharmaceuticals, and food products are safe for use.

Why Does SHC Give Us Pause?

1. Muted 5.3% annual revenue growth over the last two years shows its demand lagged behind its healthcare peers
2. Revenue base of $1.16 billion puts it at a disadvantage compared to larger competitors exhibiting economies of scale
3. Flat earnings per share over the last four years lagged its peers

Sotera Health Company is trading at $15.29 per share, or 15.9x forward P/E. To fully understand why you should be careful with SHC, check out our full research report (it’s free).

PayPal (PYPL)

Trailing 12-Month GAAP Operating Margin: 18.3%

Originally spun off from eBay in 2015 after being acquired by the auction giant in 2002, PayPal (NASDAQ: PYPL) operates a global digital payments platform that enables consumers and merchants to send, receive, and process payments online and in person.

Why Are We Hesitant About PYPL?

1. Annual sales growth of 5.6% over the last two years lagged behind its financials peers as its large revenue base made it difficult to generate incremental demand
2. Incremental sales over the last two years were less profitable as its 1.8% annual earnings per share growth lagged its revenue gains

PayPal’s stock price of $45.93 implies a valuation ratio of 8.6x forward P/E. Check out our free in-depth research report to learn more about why PYPL doesn’t pass our bar.

Stocks We Like More

ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.

Find out which 5 stocks it's flagging for this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.